Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas

Luisa Iacovelli, Antonietta Arcella, Giuseppe Battaglia, Simonetta Pazzaglia, Eleonora Aronica, Paola Spinsanti, Alessandra Caruso, Enrico De Smaele, Anna Saran, Alberto Gulino, Mara D'Onofrio, Felice Giangaspero, Ferdinando Nicoletti

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Moving from the evidence that activation of type 4 metabotropic glutamate (mGlu4) receptors inhibits proliferation and promotes differentiation of cerebellar granule cell neuroprogenitors, we examined the expression and function of mGlu4 receptors in medulloblastoma cells. mGlu4 receptors were expressed in 46 of 60 human medulloblastoma samples. Expression varied in relation to the histotype (nodular desmoplastic>classic≫large-cell anaplastic) and was inversely related to tumor severity, spreading, and recurrence. mGlu4 receptors were also found in D283med, D341med, and DAOY medulloblastoma cell lines, where receptor activation with the selective enhancer PHCCC inhibited adenylyl cyclase and the phosphatidylinositol-3-kinase pathway without affecting the mitogen-activated protein kinase, Sonic Hedgehog, and Wnt pathways. Interestingly, mGlu4 receptor activation reduced DNA synthesis and cell proliferation in all three cell lines. This effect was abrogated by the phosphatidylinositol-3-kinase inhibitor LY294002 [2-(4-morpholinyl)-8- phenyl-4H-1-benzopyran-4-one]. In in vivo experiments, repeated subcutaneous injections of N-phenyl-7-(hydroxyimino) cyclopropa[b]chromen-1a-carboxamide (PHCCC) reduced the growth of D283med and DAOY cell xenografts in nude mice. More remarkably, subcutaneous or intracranial injections of PHCCC during the first week of life prevented the development of medulloblastomas in mice lacking one Patched-1 allele and x-irradiated 1 d after birth. These data suggest that mGlu4 receptor enhancers are promising drugs for the treatment of medulloblastomas.

Original languageEnglish
Pages (from-to)8388-8397
Number of pages10
JournalJournal of Neuroscience
Volume26
Issue number32
DOIs
Publication statusPublished - Aug 9 2006

Fingerprint

Medulloblastoma
Metabotropic Glutamate Receptors
Pharmacology
Phosphatidylinositol 3-Kinase
Growth
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Cell Line
Wnt Signaling Pathway
Hedgehogs
Subcutaneous Injections
Mitogen-Activated Protein Kinases
Adenylyl Cyclases
Heterografts
Nude Mice
Alleles
Cell Proliferation
Parturition
Recurrence
Injections
DNA

Keywords

  • Cerebellum
  • Medulloblastoma
  • Metabotropic glutamate receptors
  • PHCCC
  • PI-3-K pathway
  • Proliferation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas. / Iacovelli, Luisa; Arcella, Antonietta; Battaglia, Giuseppe; Pazzaglia, Simonetta; Aronica, Eleonora; Spinsanti, Paola; Caruso, Alessandra; De Smaele, Enrico; Saran, Anna; Gulino, Alberto; D'Onofrio, Mara; Giangaspero, Felice; Nicoletti, Ferdinando.

In: Journal of Neuroscience, Vol. 26, No. 32, 09.08.2006, p. 8388-8397.

Research output: Contribution to journalArticle

Iacovelli, L, Arcella, A, Battaglia, G, Pazzaglia, S, Aronica, E, Spinsanti, P, Caruso, A, De Smaele, E, Saran, A, Gulino, A, D'Onofrio, M, Giangaspero, F & Nicoletti, F 2006, 'Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas', Journal of Neuroscience, vol. 26, no. 32, pp. 8388-8397. https://doi.org/10.1523/JNEUROSCI.2285-06.2006
Iacovelli, Luisa ; Arcella, Antonietta ; Battaglia, Giuseppe ; Pazzaglia, Simonetta ; Aronica, Eleonora ; Spinsanti, Paola ; Caruso, Alessandra ; De Smaele, Enrico ; Saran, Anna ; Gulino, Alberto ; D'Onofrio, Mara ; Giangaspero, Felice ; Nicoletti, Ferdinando. / Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas. In: Journal of Neuroscience. 2006 ; Vol. 26, No. 32. pp. 8388-8397.
@article{33052005441244518ffa13ac9f1301e1,
title = "Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas",
abstract = "Moving from the evidence that activation of type 4 metabotropic glutamate (mGlu4) receptors inhibits proliferation and promotes differentiation of cerebellar granule cell neuroprogenitors, we examined the expression and function of mGlu4 receptors in medulloblastoma cells. mGlu4 receptors were expressed in 46 of 60 human medulloblastoma samples. Expression varied in relation to the histotype (nodular desmoplastic>classic≫large-cell anaplastic) and was inversely related to tumor severity, spreading, and recurrence. mGlu4 receptors were also found in D283med, D341med, and DAOY medulloblastoma cell lines, where receptor activation with the selective enhancer PHCCC inhibited adenylyl cyclase and the phosphatidylinositol-3-kinase pathway without affecting the mitogen-activated protein kinase, Sonic Hedgehog, and Wnt pathways. Interestingly, mGlu4 receptor activation reduced DNA synthesis and cell proliferation in all three cell lines. This effect was abrogated by the phosphatidylinositol-3-kinase inhibitor LY294002 [2-(4-morpholinyl)-8- phenyl-4H-1-benzopyran-4-one]. In in vivo experiments, repeated subcutaneous injections of N-phenyl-7-(hydroxyimino) cyclopropa[b]chromen-1a-carboxamide (PHCCC) reduced the growth of D283med and DAOY cell xenografts in nude mice. More remarkably, subcutaneous or intracranial injections of PHCCC during the first week of life prevented the development of medulloblastomas in mice lacking one Patched-1 allele and x-irradiated 1 d after birth. These data suggest that mGlu4 receptor enhancers are promising drugs for the treatment of medulloblastomas.",
keywords = "Cerebellum, Medulloblastoma, Metabotropic glutamate receptors, PHCCC, PI-3-K pathway, Proliferation",
author = "Luisa Iacovelli and Antonietta Arcella and Giuseppe Battaglia and Simonetta Pazzaglia and Eleonora Aronica and Paola Spinsanti and Alessandra Caruso and {De Smaele}, Enrico and Anna Saran and Alberto Gulino and Mara D'Onofrio and Felice Giangaspero and Ferdinando Nicoletti",
year = "2006",
month = "8",
day = "9",
doi = "10.1523/JNEUROSCI.2285-06.2006",
language = "English",
volume = "26",
pages = "8388--8397",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "32",

}

TY - JOUR

T1 - Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas

AU - Iacovelli, Luisa

AU - Arcella, Antonietta

AU - Battaglia, Giuseppe

AU - Pazzaglia, Simonetta

AU - Aronica, Eleonora

AU - Spinsanti, Paola

AU - Caruso, Alessandra

AU - De Smaele, Enrico

AU - Saran, Anna

AU - Gulino, Alberto

AU - D'Onofrio, Mara

AU - Giangaspero, Felice

AU - Nicoletti, Ferdinando

PY - 2006/8/9

Y1 - 2006/8/9

N2 - Moving from the evidence that activation of type 4 metabotropic glutamate (mGlu4) receptors inhibits proliferation and promotes differentiation of cerebellar granule cell neuroprogenitors, we examined the expression and function of mGlu4 receptors in medulloblastoma cells. mGlu4 receptors were expressed in 46 of 60 human medulloblastoma samples. Expression varied in relation to the histotype (nodular desmoplastic>classic≫large-cell anaplastic) and was inversely related to tumor severity, spreading, and recurrence. mGlu4 receptors were also found in D283med, D341med, and DAOY medulloblastoma cell lines, where receptor activation with the selective enhancer PHCCC inhibited adenylyl cyclase and the phosphatidylinositol-3-kinase pathway without affecting the mitogen-activated protein kinase, Sonic Hedgehog, and Wnt pathways. Interestingly, mGlu4 receptor activation reduced DNA synthesis and cell proliferation in all three cell lines. This effect was abrogated by the phosphatidylinositol-3-kinase inhibitor LY294002 [2-(4-morpholinyl)-8- phenyl-4H-1-benzopyran-4-one]. In in vivo experiments, repeated subcutaneous injections of N-phenyl-7-(hydroxyimino) cyclopropa[b]chromen-1a-carboxamide (PHCCC) reduced the growth of D283med and DAOY cell xenografts in nude mice. More remarkably, subcutaneous or intracranial injections of PHCCC during the first week of life prevented the development of medulloblastomas in mice lacking one Patched-1 allele and x-irradiated 1 d after birth. These data suggest that mGlu4 receptor enhancers are promising drugs for the treatment of medulloblastomas.

AB - Moving from the evidence that activation of type 4 metabotropic glutamate (mGlu4) receptors inhibits proliferation and promotes differentiation of cerebellar granule cell neuroprogenitors, we examined the expression and function of mGlu4 receptors in medulloblastoma cells. mGlu4 receptors were expressed in 46 of 60 human medulloblastoma samples. Expression varied in relation to the histotype (nodular desmoplastic>classic≫large-cell anaplastic) and was inversely related to tumor severity, spreading, and recurrence. mGlu4 receptors were also found in D283med, D341med, and DAOY medulloblastoma cell lines, where receptor activation with the selective enhancer PHCCC inhibited adenylyl cyclase and the phosphatidylinositol-3-kinase pathway without affecting the mitogen-activated protein kinase, Sonic Hedgehog, and Wnt pathways. Interestingly, mGlu4 receptor activation reduced DNA synthesis and cell proliferation in all three cell lines. This effect was abrogated by the phosphatidylinositol-3-kinase inhibitor LY294002 [2-(4-morpholinyl)-8- phenyl-4H-1-benzopyran-4-one]. In in vivo experiments, repeated subcutaneous injections of N-phenyl-7-(hydroxyimino) cyclopropa[b]chromen-1a-carboxamide (PHCCC) reduced the growth of D283med and DAOY cell xenografts in nude mice. More remarkably, subcutaneous or intracranial injections of PHCCC during the first week of life prevented the development of medulloblastomas in mice lacking one Patched-1 allele and x-irradiated 1 d after birth. These data suggest that mGlu4 receptor enhancers are promising drugs for the treatment of medulloblastomas.

KW - Cerebellum

KW - Medulloblastoma

KW - Metabotropic glutamate receptors

KW - PHCCC

KW - PI-3-K pathway

KW - Proliferation

UR - http://www.scopus.com/inward/record.url?scp=33748186195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748186195&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.2285-06.2006

DO - 10.1523/JNEUROSCI.2285-06.2006

M3 - Article

C2 - 16899734

AN - SCOPUS:33748186195

VL - 26

SP - 8388

EP - 8397

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 32

ER -